No Data
INNOVATIVE PHAR (00399.HK) plans to appoint Yongtuo Fuxin as the new auditor.
Gelonghui reported on March 7 that INNOVATIVE PHAR (00399.HK) announced the proposal to appoint Yongtuo Fuxin Accounting Firm Limited ("Yongtuo Fuxin") as the company's new auditor, serving as the company's auditor until the conclusion of the next Shareholder Annual General Meeting.
INNOVATIVE PHAR (00399.HK): Zheng Deyao resigns as Executive Director.
Gelonghui reported on March 4 that INNOVATIVE PHAR (00399.HK) announced that the Board of Directors has stated that Zheng Deyao has resigned as executive director, effective from March 4, 2025.
INNOVATIVE PHAR (00399.HK): Li Jiehong has been appointed as Executive Director.
Glory Financial on February 11 announced that INNOVATIVE PHAR (00399.HK) will implement the following changes from February 11, 2025: (i) Wu Yanmin has resigned as a non-executive Director; (ii) Xiao Yan has resigned as a non-executive Director; (iii) Li Jiehong has been appointed as an executive Director; (iv) Qi Shujuan has been appointed as an executive Director.
Express News | Innovative Pharmaceutical Biotech - Li Jiehong Has Been Appointed as an Executive Director
INNOVATIVE PHAR: Interim Report 2024-2025
INNOVATIVE PHAR plans to receive investment of 48 million HKD from new investors.
INNOVATIVE PHAR (00399) announced that on approximately December 10, 2024, the company will enter into a main agreement with investors...
Innovative Pharmaceutical Biotech (HKG:399) Is Posting Solid Earnings, But It Is Not All Good News
